Meeting of the National Vaccine Advisory Committee, 2107-2108 [2015-00519]
Download as PDF
Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices
2107
EARLY TERMINATIONS GRANTED—Continued
[December 1, 2014 thru December 31, 2014]
12/30/2014
20150118 ......
G
Siemens Aktiengesellschaft; Dresser-Rand Group Inc.; Siemens Aktiengesellschaft.
12/31/2014
20150360
20150368
20150369
20150374
20150375
20150379
20150381
20150385
......
......
......
......
......
......
......
......
G
G
G
G
G
G
G
G
Aviation Industry Corporation of China; Greenbriar Equity Fund II, L.P.; Aviation Industry Corporation of China.
Deutsche Telekom AG; Paul G. Allen; Deutsche Telekom AG.
BlackRock, Inc.; BlackRock Kelso Capital Advisors LLC; BlackRock, Inc.
RenaissanceRe Holdings Ltd.; Platinum Underwriters Holdings, Ltd.; RenaissanceRe Holdings Ltd.
Gilles Martin; Bain Capital Venture Fund 2009, L.P.; Gilles Martin.
AMN Healthcare Services, Inc.; Welsh, Carson Anderson & Stowe IX, L.P.; AMN Healthcare Services, Inc.
Wind Point Partners VI, L.P.; The Dow Chemical Company; Wind Point Partners VI, L.P.
Dominion Resources, Inc; SCANA Corporation; Dominion Resources, Inc.
FOR FURTHER INFORMATION CONTACT:
By direction of the Commission.
Donald Clark,
Secretary.
[FR Doc. 2015–00515 Filed 1–14–15; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Minority Health
Office of the Secretary, Office
of Minority Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the Advisory Committee on
Minority Health (ACMH) will hold a
meeting. This meeting will be open to
the public. Preregistration is required
for both public attendance and
comment. Any individual who wishes
to attend the meetings and/or
participate in the public comment
session should email OMH-ACMH@
hhs.gov.
SUMMARY:
The meeting will be held on
Thursday, February 12, 2015, from 9:00
a.m. to 5:00 p.m. and on Friday,
February 13, 2015, from 9:00 a.m. to
1:00 p.m.
ADDRESSES: The meeting will be held at
the Hubert H. Humphrey Building, 200
Independence Avenue SW.,
Washington, DC 20201, Room 505A.
rljohnson on DSK3VPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
14:13 Jan 14, 2015
Jkt 235001
Dr.
Rashida Dorsey, Designated Federal
Officer, ACMH; OMH-ACMH@hhs.gov,
Tower Building, 1101 Wootton
Parkway, Suite 600, Rockville,
Maryland 20852. Phone: 240–453–8222,
Fax: 240–453–8223.
SUPPLEMENTARY INFORMATION: In
accordance with Public Law 105–392,
the ACMH was established to provide
advice to the Deputy Assistant Secretary
for Minority Health in improving the
health of each racial and ethnic
minority group and on the development
of goals and specific program activities
of the Office of Minority Health.
Topics to be discussed during these
meetings will include strategies to
improve the health of racial and ethnic
minority populations through the
development of health policies and
programs that will help eliminate health
disparities, as well as other related
issues.
Public attendance at this meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person at least
fourteen (14) business days prior to the
meeting. Members of the public will
have an opportunity to provide
comments at the meeting. Public
comments will be limited to three
minutes per speaker. Individuals who
would like to submit written statements
should mail or fax their comments to
the Office of Minority Health at least
seven (7) business days prior to the
meeting. Any members of the public
who wish to have printed material
distributed to ACMH committee
members should submit their materials
to the Designated Federal Officer,
ACMH, Tower Building, 1101 Wootton
Parkway, Suite 600, Rockville,
Maryland 20852, prior to close of
business Thursday, February 5, 2015.
FOR FURTHER INFORMATION CONTACT:
Renee Chapman, Contact
Representative, or Theresa Kingsberry,
Legal Assistant, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room
CC–5301, Washington, DC 20024, (202)
326–3100.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Dated: January 6, 2015.
Rashida Dorsey,
Designated Federal Officer, ACMH, Office of
Minority Health, U.S. Department of Health
and Human Services.
[FR Doc. 2015–00520 Filed 1–14–15; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
National Vaccine Program
Office, Office of the Assistant Secretary
for Health, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting
February 10–11, 2015. The meeting is
open to the public. However, preregistration is required for both public
attendance and public comment.
Individuals who wish to attend the
meeting and/or participate in the public
comment session should register at
https://www.hhs.gov/nvpo/nvac.
Participants may also register by
emailing nvpo@hhs.gov or by calling
202–690–5566 to provide your name,
organization, and email address.
DATES: The meeting will be held on
February 10–11, 2015. The meeting
times and agenda will be posted on the
NVAC Web site at https://www.hhs.gov/
nvpo/nvac as soon they become
available.
ADDRESSES: U.S. Department of Health
and Human Services, Hubert H.
Humphrey Building, Great Hall, 200
Independence Avenue SW.,
Washington, DC 20201.
SUMMARY:
E:\FR\FM\15JAN1.SGM
15JAN1
2108
Federal Register / Vol. 80, No. 10 / Thursday, January 15, 2015 / Notices
The meeting can also be accessed
through a live webcast the day of the
meeting. For more information, visit
https://www.hhs.gov/nvpo/nvac/
meetings/upcomingmeetings/
index.html.
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; email: nvpo@
hhs.gov.
Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The NVAC was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
The topics planned for the February
NVAC meeting will include a number of
sessions addressing vaccine innovation.
The NVAC will hear about current U.S.
government-wide strategies to combat
antimicrobial resistance followed by a
panel discussion on the role vaccines
(both existing and new) could play in
those strategies. The Institute of
Medicine will present their recently
released report on the Strategic MultiAttribute Ranking Tool for Vaccines
(SMART-Vaccines) software developed
to support prioritization of new vaccine
research and development. NVAC will
then hear from beta-testers of the
SMART-Vaccine software about their
experience and possible uses for the tool
going forward. NVAC will also discuss
the on-going efforts to better understand
and overcome the barriers to sharing
immunization registry data between
states.
NVAC will preview both the National
Vaccine Annual Report and the National
Adult Immunization Plan. In addition,
the Vaccine Confidence/Acceptance and
the NVAC HPV working groups will
present their draft report and draft
recommendations for NVAC
consideration and discussion. Finally,
the NVAC Maternal Immunization and
the NVAC Mid-Course Review Working
Groups will provide an update on their
progress. The meeting agenda will be
posted on the NVAC Web site: https://
rljohnson on DSK3VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
14:13 Jan 14, 2015
Jkt 235001
www.hhs.gov/nvpo/nvac prior to the
meeting.
Public attendance at the meeting is
limited to the available space.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the National Vaccine Program
Office at the address/phone listed above
at least one week prior to the meeting.
For those unable to attend in person, a
live webcast will be available. More
information on registration and
accessing the webcast can be found at
https://www.hhs.gov/nvpo/nvac/
meetings/upcomingmeetings/
index.html.
Members of the public will have the
opportunity to provide comments at the
NVAC meeting during the public
comment periods designated on the
agenda. Individuals who would like to
submit written statements should email
their comments to the National Vaccine
Program Office (nvpo@hhs.gov) at least
five business days prior to the meeting.
Dated: 12 January 2015.
Bruce Gellin,
Executive Secretary, National Vaccine
Advisory Committee, Deputy Assistant
Secretary for Health, Director, National
Vaccine Program Office.
[FR Doc. 2015–00519 Filed 1–14–15; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Advisory
Committee on Minority Health
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice for solicitation of
Advisory Committee on Minority Health
members.
AGENCY:
Authority: 42 U.S.C. 300u–6, Section 1707
of the Public Health Service Act, as amended.
The Advisory Committee is governed by
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of
advisory committees.
The Department of Health and
Human Services (HHS), Office of
Minority Health (OMH), is seeking
nominations of qualified candidates to
be considered for appointment as a
member of the Advisory Committee on
Minority Health (hereafter referred to as
the ‘‘Committee or ACMH’’). In
accordance with Public Law 105–392,
the Committee provides advice to the
Deputy Assistant Secretary for Minority
SUMMARY:
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
Health on improving the health of racial
and ethnic minority groups, and on the
development of goals and specific
program activities of OMH designed to
improve the health status and outcomes
of racial and ethnic minorities.
Nominations of qualified candidates are
being sought to fill vacancies on the
Committee.
DATES: Nominations for membership on
the Committee must be received no later
than 5:00 p.m. EST on April 15, 2015,
at the address listed below.
ADDRESSES: All nominations should be
mailed to Dr. Rashida Dorsey,
Designated Federal Officer, Advisory
Committee on Minority Health, Office of
Minority Health, Department of Health
and Human Services, 1101 Wootton
Parkway, Suite 600, Rockville, MD
20852.
FOR FURTHER INFORMATION CONTACT: Dr.
Rashida Dorsey, Designated Federal
Officer, Advisory Committee on
Minority Health, Office of Minority
Health, Department of Health and
Human Services, Tower Building, 1101
Wootton Parkway, Suite 600, Rockville,
Maryland 20852. Phone: 240–453–8222;
fax: 240–453–8223.
A copy of the ACMH charter and list
of the current membership can be
obtained by contacting Dr. Dorsey or by
accessing the Web site managed by
OMH at www.minorityhealth.hhs.gov.
Information about ACMH activities can
be found on the OMH Web site under
the heading About OMH.
SUPPLEMENTARY INFORMATION: Pursuant
to Public Law 105–392, the Secretary of
Health and Human Services established
the ACMH. The Committee provides
advice to the Deputy Assistant Secretary
for Minority Health in carrying out the
duties stipulated under Public Law 105–
392. This includes providing advice on
improving the health of racial and
ethnic minority populations and in the
development of goals and specific
program activities of OMH, which are
to:
(1) Establish short-range and longrange goals and objectives and
coordinate all other activities within the
Public Health Service that relate to
disease prevention, health promotion,
service delivery, and research impacting
racial and ethnic minority populations;
(2) enter into interagency agreements
with other agencies of the Public Health
Service;
(3) support research, demonstrations,
and evaluations to test new and
innovative models;
(4) increase knowledge and
understanding of health risk factors;
(5) develop mechanisms that support
better information dissemination,
E:\FR\FM\15JAN1.SGM
15JAN1
Agencies
[Federal Register Volume 80, Number 10 (Thursday, January 15, 2015)]
[Notices]
[Pages 2107-2108]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-00519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: National Vaccine Program Office, Office of the Assistant
Secretary for Health, Office of the Secretary, Department of Health and
Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a meeting
February 10-11, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment.
Individuals who wish to attend the meeting and/or participate in the
public comment session should register at https://www.hhs.gov/nvpo/nvac.
Participants may also register by emailing nvpo@hhs.gov or by calling
202-690-5566 to provide your name, organization, and email address.
DATES: The meeting will be held on February 10-11, 2015. The meeting
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon they become available.
ADDRESSES: U.S. Department of Health and Human Services, Hubert H.
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington,
DC 20201.
[[Page 2108]]
The meeting can also be accessed through a live webcast the day of
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S.
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone:
(202) 690-5566; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The NVAC was established to provide advice and
make recommendations to the Director of the National Vaccine Program on
matters related to the Program's responsibilities. The Assistant
Secretary for Health serves as Director of the National Vaccine
Program.
The topics planned for the February NVAC meeting will include a
number of sessions addressing vaccine innovation. The NVAC will hear
about current U.S. government-wide strategies to combat antimicrobial
resistance followed by a panel discussion on the role vaccines (both
existing and new) could play in those strategies. The Institute of
Medicine will present their recently released report on the Strategic
Multi-Attribute Ranking Tool for Vaccines (SMART-Vaccines) software
developed to support prioritization of new vaccine research and
development. NVAC will then hear from beta-testers of the SMART-Vaccine
software about their experience and possible uses for the tool going
forward. NVAC will also discuss the on-going efforts to better
understand and overcome the barriers to sharing immunization registry
data between states.
NVAC will preview both the National Vaccine Annual Report and the
National Adult Immunization Plan. In addition, the Vaccine Confidence/
Acceptance and the NVAC HPV working groups will present their draft
report and draft recommendations for NVAC consideration and discussion.
Finally, the NVAC Maternal Immunization and the NVAC Mid-Course Review
Working Groups will provide an update on their progress. The meeting
agenda will be posted on the NVAC Web site: https://www.hhs.gov/nvpo/nvac prior to the meeting.
Public attendance at the meeting is limited to the available space.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the National Vaccine Program Office at the address/phone listed
above at least one week prior to the meeting. For those unable to
attend in person, a live webcast will be available. More information on
registration and accessing the webcast can be found at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
Members of the public will have the opportunity to provide comments
at the NVAC meeting during the public comment periods designated on the
agenda. Individuals who would like to submit written statements should
email their comments to the National Vaccine Program Office
(nvpo@hhs.gov) at least five business days prior to the meeting.
Dated: 12 January 2015.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy
Assistant Secretary for Health, Director, National Vaccine Program
Office.
[FR Doc. 2015-00519 Filed 1-14-15; 8:45 am]
BILLING CODE 4150-44-P